Search results
Results from the WOW.Com Content Network
Dyshidrosis is diagnosed clinically by gathering a patient's history and making observations. [8] Allergy testing and culture may be done to rule out other problems. [8] Severity of symptoms can also be assessed using the dyshidrotic eczema area and severity index (DASI), although it was designed for clinical trials and is not typically used in ...
In the last couple of years an internal medicine has been approved for the first time for the treatment of chronic hand eczema. [14] [15] [16] This involves a derivative of vitamin A, called alitretinoin, which is also naturally present in the human body. Alitretinoin can be used to treat all forms of severe chronic hand eczema which have not ...
In cases of short duration, there may be small blisters, while in long-term cases the skin may become thickened. [1] The area of skin involved can vary from small to covering the entire body. [ 1 ] [ 2 ] Dermatitis is also called eczema but the same term is often used for the most common type of skin inflammation, atopic dermatitis .
This page was last edited on 19 January 2010, at 23:30 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
This section does not cite any sources. Please help improve this section by adding citations to reliable sources . Unsourced material may be challenged and removed .
Atopic dermatitis (AD), also known as atopic eczema, is a long-term type of inflammation of the skin. [2] Atopic dermatitis is also often called simply eczema but the same term is also used to refer to dermatitis, the larger group of skin conditions. [2] [5] Atopic dermatitis results in itchy, red, swollen, and cracked skin. [2]
Chilblains, also known as pernio, is a medical condition in which damage occurs to capillary beds in the skin, most often in the hands or feet, when blood perfuses into the nearby tissue, resulting in redness, itching, inflammation, and possibly blisters.
Also, improvement in treatments has significantly extended the lifespans of patients with chronic diseases but results in additional costs over long period of time. A striking success is the development of combined antiviral therapies that led to remarkable improvement in survival rates and quality of life of HIV -infected patients.